![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
VG Life Sciences Granted Combination Cancer Drug Patent U.S. Patent Covers Group of Compounds Combined With Existing Treatments To Fight Drug-Resistant Cancers PR Newswire SANTA BARBARA, Calif...
VGLS Notes Key Patents, License and Other Major Achievements in the First Half of 2015 PR Newswire SANTA BARBARA, Calif., June 16, 2015 SANTA BARBARA, Calif., June 16, 2015 /PRNewswire/ -- Dear...
VG Life Sciences Granted Key Composition Of Matter Patent U.S. Patent Covers Synthetic Peptide That Displaces Ectopic CLIP in Chronic Inflammatory Conditions, Autoimmune Disease and Infection PR...
SANTA BARBARA, Calif., June 23, 2014 (GLOBE NEWSWIRE) -- VG Life Sciences, Inc. (VGLS) is a publically traded biotechnology company focused on developing treatments for patients suffering from...
SANTA BARBARA, Calif., May 13, 2014 (GLOBE NEWSWIRE) -- VG Life Sciences Inc. releases a Q1 2014 Shareholder Update Letter: May 13, 2014 Dear Shareholders, Here at VG Life Sciences, our...
SANTA BARBARA, Calif., May 1, 2014 (GLOBE NEWSWIRE) -- VG Life Sciences (VGLS) is a publically traded biotechnology company focused on developing treatments for patients suffering from autoimmune...
SANTA BARBARA, Calif., March 14, 2014 (GLOBE NEWSWIRE) -- VG Life Sciences, (OTC Pink:VGLS) a biotechnology company, announces today an update to its Physician-IND Phase I Study to test...
SANTA BARBARA, Calif., Jan. 3, 2014 (GLOBE NEWSWIRE) -- VG Life Sciences, Inc., (OTC Pink: VGLS) a biotechnology company. Pursuant to a vote of the holders having a majority of the...
VG Life Sciences, Inc. Update on Phase I Cancer Study PR Newswire SANTA BARBARA, Calif., Dec. 13, 2013 SANTA BARBARA, Calif., Dec. 13, 2013 /PRNewswire/ -- VG Life Sciences, (OTC Pink: VGLS) a...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.502 | 2.49187163386 | 20.1455 | 21.21 | 20.1455 | 10434 | 20.71400013 | CS |
4 | -0.3525 | -1.67857142857 | 21 | 22 | 19.11 | 16752 | 20.46891408 | CS |
12 | -2.6275 | -11.2889366273 | 23.275 | 24.44 | 19.11 | 14388 | 21.97922159 | CS |
26 | 0.9375 | 4.75646879756 | 19.71 | 24.84 | 19.11 | 22660 | 21.54641856 | CS |
52 | -2.9425 | -12.4735057228 | 23.59 | 24.952 | 18.1923 | 28962 | 21.26256738 | CS |
156 | 11.6175 | 128.65448505 | 9.03 | 32.53 | 9.03 | 28004 | 21.90997811 | CS |
260 | 16.1475 | 358.833333333 | 4.5 | 32.53 | 0.58 | 22050 | 18.30738717 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions